Generation of Chimeric “ABS Nanohemostat” Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model

Table 1

Comparison of warm ischemia time (WIT) and amount of bleeding (AOB) in study groups.

	WIT (sec)	AOB (cm^2)
Group 1 (𝑛=6)	232.8 ± 56.3	7.3 ± 3.3
Group 2 (𝑛=6)	65.6 ± 11.4	5.7 ± 2.3
Group 3 (𝑛=6)	75.5 ± 17.2	5.2 ± 3.2
Group 4 (𝑛=6)	58.1 ± 17.6	16.4 ± 7.7
𝑃	0.003*	0.035**

 *G1 versus G2 𝑃=0.0002; G1 versus G3 𝑃=0.002; G1 versus G4 𝑃=0.002; G2 versus G3 𝑃=0.31; G2 versus G4 𝑃=0.699; G3 versus G4 𝑃=0.24.
**G1 versus G2 𝑃=0.48; G1 versus G3 𝑃=0.39; G1 versus G4 𝑃=0.035; G2 versus G3 𝑃=0.69; G2 versus G4 𝑃=0.015; G3 versus G4 𝑃=0.015.